Imlifidase

Name: Imlifidase in Kidney transplantation in highly sensitized patients: Effects of Imlifidase on other drugs
Published: 2026-09-14T15:39:06-04:00

Kidney transplantation in highly sensitized patients

Manufacturer: Hansa Biopharma
Regulatory submission: BLA submitted December 2025
Launch: Anticipated in the first quarter of 2027
Last updated: September 19, 2026

Section

Product information and disease description Product description Product information Drug/Drug, drug/disease interactions

Effects of Imlifidase on other drugs

1 evidence topic · 1 source

Potential impairment of alemtuzumab activity after imlifidase

“Alemtuzumab may not be effective on Day 4 in some patients (as imlifidase may still be active).” (opens the source at this quote in a new tab)